Clinical and Functional Criteria for the Vital Activity of Patients and Disabled People Suffering from Presbyopia

The purpose : to evaluate the therapeutic effect of Quinax, administered by the method of triple instillations for 6 months to patients with presbyopia in order to determine its effect on the development of refractive errors in this category of patients. Patients and methods . The treatment was carried out in 60 patients with an average age of 43 ± 2 years, suffering from presbyopia. At the same time, the main group consisted of 30 patients who were treated with Quinax when it was administered by the method of triple instillations for 12 months. The comparison group consisted of 30 people who underwent treatment of presbyopia by other conservative methods. Each patient underwent an ophthalmological examination, which included: visometry, perimetry, refractometry, biomicroscopy, ophthalmoscopy, visual performance study, dark adaptation, and complaints were analyzed in order to establish their impact on the quality of life in patients and disabled people with cataracts and presbyopia. Results . The results of the study showed the effectiveness of the use of Quinax when administered by the method of three instillations for 12 months and revealed stabilization of changes in visual acuity and visual field to white, red and green colors, reduction of visual fatigue due to reduction of glare, stabilization of dark adaptation and refraction. Conclusion . From the above research data, it can be seen that treatment with Quinax drops gives positive results both functionally and subjectively. The results obtained during the study provide the basis for the recommendation of the drug “Quinax” to all patients with presbyopia.